- Home
- Products
- Customized FluoroAb™
- ERBB3
- Patritumab-iFluor 350
Patritumab-iFluor 350 (CAT#: ADC-FL-1387)
This product is comprised of an anti-ERBB3 monoclonal antibody (Patritumab) labeled with iFluor 350. iFluor 350 is a blue-fluorescent dye and it's excitation/emission is 346/442 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- ERBB3
- Alternative Names
- ERBB3; v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian); LCCS2, lethal congenital contracture syndrome 2; receptor tyrosine-protein kinase erbB-3; HER3; proto-oncogene-like protein c-ErbB-3; tyrosine kinase-type cell surface receptor HER3; LCCS2; ErbB-3; c-erbB3; erbB3-S; MDA-BF-1; c-erbB-3; p180-ErbB3; p45-sErbB3; p85-sErbB3; MGC88033;
- Overview
- This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported, but they have not been thoroughly characterized.
- Overview
- Human Anti-ERBB3 IgG1-kappa antibody, Patritumab
- Generic name
- Patritumab
- Species Reactivity
- Human
- Name
- iFluor 350
- Color
- Blue
- Excitation⁄Emission (nm)
- 346/442
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-GUCY2C MAb (Clone 4)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS958)
- Anti-TNF MAb (Clone 12)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15355)
- Anti-EDA MAb (Clone 4)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11753)
- Anti-SLITRK6 MAb (Clone 2)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3561)
- Anti-ITGA5 MAb (Clone 1)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9875)
- Anti-LAMP1 MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS281)
- Anti-VEGFA MAb (Clone 7)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15388)
- Anti-IgG Fc MAb (Clone 6)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3646)
- Anti-MS4A1 MAb (Clone 22)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7046)
- Anti-ITGA4 MAb (Clone 3)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS7834)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-1387. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-2242 | Anti-ERBB3 (Duligotumab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-2241 | Anti-ERBB3 (Duligotumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-2244 | Anti-ERBB3 (Duligotumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-2366 | Anti-ERBB3 (Duligotuzumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-2371 | Anti-ERBB3 (Duligotuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
